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Abstract 
Thyroid hormone (T 3) and insulin are both shown to stimulate glucose transport in Clone 9 cells, a rat liver cell line in 
which the utilization of glucose is limited by transport ate and in which only the GLUT-1 transporter isoform is expressed. 
Pre-treatment of these cells with T 3 moreover substantially enhances the stimulatory effect of insulin such that at maximally 
effective hormone concentrations the effects of T 3 and insulin on glucose transport are more than additive and indeed nearly 
multiplicative, suggesting that the mechanisms mediating the enhancement of glucose transport differ between the two 
hormones. Cell surface biotinylation followed by Western-blot analysis of plasma membrane fractions showed that the 
stimulatory effects of T 3 and insulin on glucose transport, whether acting singly or in combination, exceed the attendant 
increases in the abundance of GLUT-1 in the plasma membrane. It is suggested that activation of GLUT-1 molecules 
pre-existing in the plasma membrane plays a major role in mediating the stimulatory effects of T 3 and insulin on glucose 
transport in this cell line. 
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1. Introduction 
A large body of evidence now suggests that the 
dominant mechanism mediating the stimulation of 
glucose transport by insulin in target tissues is a 
translocation of glucose transporters to the plasma 
membrane [1-9]. Results of other studies, however, 
indicate that the enhancement of transport by insulin 
is additionally mediated by an activation of glucose 
transporter sites pre-existing in the plasma membrane 
[8,10-12]. It has likewise been suggested that the 
stimulation of glucose transport by thyroid hormone 
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(T3) similarly reflects both a translocation of glucose 
transporters to the plasma membrane [13-15] and an 
enhancement of the catalytic activity of individual 
transporter molecules [14,16]. The fact that glucose 
transport is enhanced by both T 3 and insulin raises 
the possibility that pre-treatment of cells with T 3 
might enhance the stimulatory effect of insulin if the 
mechanisms by which Z 3 and insulin enhance trans- 
port are different. Previous studies in human subjects 
have shown, for example, that the administration of
excess thyroid hormone not only increases 'basal' 
glucose transport and utilization [17,18] but results in 
an exaggerated glucose transport response at maxi- 
mally effective plasma insulin concentrations [17]. 
To further investigate the augmentation f insulin 
action in the hyperthyroid state, and to explore the 
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mechanisms mediating such augmentation, we have 
examined the effects of '1" 3 and insulin, acting singly 
and in concert, on both glucose transport activity and 
plasma membrane glucose transporter abundance in 
Clone 9 cells, a non-transformed cell line derived 
from normal rat liver [19,]. Clone 9 cells were chosen 
for these studies because they have previously been 
shown to respond to T 3 with a substantial enhance- 
ment of glucose transport [14,20]. Glucose 
metabolism in Clone 9 ,=ells moreover is limited by 
glucose transport rate, and intracellular glucose con- 
centrations are less than 10% of that in the external 
medium [21]. A particularly useful property of these 
cells is that they express only the GLUT-1 isoform of 
the glucose transporter, a characteristic that greatly 
simplifies analysis of experimental results. 
2.2. Cell culture 
Clone 9 cells [19] were maintained in Dulbecco's 
modified Eagle's medium (DMEM) containing 5.6 
mM glucose and supplemented with 10% calf serum 
as previously described [20]. For experiments defin- 
ing the effects of thyroid hormone, cells were pas- 
saged at 1:8 dilution and seeded onto 60- or 100-ram 
culture dishes in 4 or 10 ml, respectively, of DMEM 
containing 10% calf serum that had been depleted of 
thyroxine and triiodothyronine by the method of 
Samuels et al. [23]. At confluence (~ 4 days after 
passage) the medium was replaced with fresh DMEM 
containing 10% thyroid hormone-deficient serum, and 
experiments were begun 24 h later by the addition of 
either T 3 or diluent alone (10% ethanol). 
2. Materials and methods 
2.1. Materials 
Clone 9 cells were obtained from the American 
Type Culture Collection (Rockville, MD) and were 
used between the 35th and 42nd passages. 3-0- 
Methyl-D-[3H]glucose ([3H]3-OMG) (2.4-3.9 
Ci/mmol) and Enhanced Chemiluminescence kits 
were purchased from Amersham (Chicago, IL). An- 
ion-exchange resin AG l-X8 of analytical grade 
(chloride form) was obtained from Bio-Rad (Rich- 
mond, CA). Phloretin, cytochalasin B, phenylmethyl- 
sulfonyl chloride (PMSF), N-tosyl-L-lysine 
chloromethyl ketone (TLCK), N-tosyl-L-phenyl- 
alanine chloromethyl ketone (TPCK), crystalline 
bovine pancreatic nsulin, L-triiodothyronine (T3), and 
standard chemicals were purchased from Sigma (St. 
Louis, MO). Nitrocellulose paper (BA85) was ob- 
tained from Schleicher and Schuell (Keene, NH). 
Rabbit polyclonal antiserum against the COOH- 
terminal 13-amino-acid sequence of GLUT-1 [22] 
was purchased from East Acres Biologicals (South- 
bridge, MA). Calf serum and culture medium were 
purchased from Gibco BRL (Gaithersburg, MD). 
Plastic culture dishes were obtained from Coming 
Glass Works (Medfield, MA). NHS-LC-biotin, 
streptavidin-agarose beads, and Micro BCA protein 
assay reagent were purchased from the Pierce Chemi- 
cal Co. (Rockford, IL). 
2.3. Measurement of [3H]3-OMG uptake rate 
Confluent cells on 60-mm culture plates in tripli- 
cate were used as previously described [14]. The 
uptake medium consisted of DMEM (containing 5.6 
mM glucose) to which tracer quantities (7.5 ixCi/ml) 
of [3H]3-OMG had been added [14]. Uptake intervals 
(usually 80 s) were employed such that accumulation 
of [3H]3-OMG did not exceed 20% of the steady-state 
value. Cytochalasin B-inhibitable [3H]3-OMG uptake 
rate was calculated as the difference between the 
uptake rate determined in parallel in triplicate plates 
in the absence and in the presence of 50 txM cyto- 
chalasin B [24,25]. Standard errors for the differences 
were calculated to take into account the standard 
deviations and the number of plates corresponding to 
each group [26]. 
2.4. Cell surface biotinylation and preparation of 
plasma membrane fractions 
100-mm plates of confluent cells (three plates for 
each experimental condition) were rinsed twice with 
8 ml of ice-cold phosphate-buffered saline followed 
by the addition of 1.5 ml of cold biotinylation buffer 
(120 mM NaC1, 30 mM NaHCO 3, and 5 mM KC1 at 
pH 8.5) containing 0.1 mg/ml  freshly added NHS-LC 
biotin. After 30 min of gentle swirling at 4°C the 
medium was aspirated and the plates were washed 
three times with 5 ml of buffer containing 140 mM 
NaC1, 20 mM Tris, and 5 mM KC1 at pH 7.5. Cells 
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from each set of three plates were then scraped and 
pooled in 1 ml of hypotonic homogenization buffer 
containing 10 mM NaHCO 3 and 100 IxM each of 
TPCK, TLCK, and PMSF. After 10 min on ice the 
cells were homogenized in a Dounce homogenizer 
with 20 strokes of a tightly fitting pestle (Blaessig 
Glass Co., Rochester, NY), and 100 txl of buffer 
containing 1.5 M NaC1 and 100 mM Tris (pH 7.0) 
was added. Following removal of a 100-txl sample 
the homogenates were spun for 15 s at maximum 
speed in an Eppendorf Microfuge (Brinkmann Instru- 
ments, Westbury, NY) to sediment nuclei. 100 ixl of 
each resulting post-nuclear supernatant was set aside 
for subsequent assays, the remainder was added to 
1.5-ml Eppendorf Microfuge tubes containing 50 txl 
of streptavidin-agarose beads that had been sedi- 
mented following pre-equilibration with 1 ml of ho- 
mogenization buffer, and an additional 5 Ixl of 20 
mM PMSF was added to each mixture. After gentle 
mixing of the samples by repeated inversion at 4°C 
for 30 min the beads were pelleted, the resulting 
supernatants ('vesicle fractions') were reserved, and 
the pellets were washed three times with 1 ml of 
homogenization buffer containing freshly added pro- 
tease inhibitors. The final pellets were then resus- 
pended in 120 Ixl of 1.2 X Laemmli buffer [27] lack- 
ing both mercaptoethanol and bromphenol blue and 
incubated at 65°C for 30 min with occasional shak- 
ing. The beads were once again briefly pelleted and 
the supernatants (approximately 120 txl in volume) 
containing solubilized plasma membrane were re- 
moved and frozen overnight prior to use. Because of 
the presence of high concentrations of sodium dode- 
cyl sulfate (SDS) in some of the samples, the protein 
content of all fractions was determined by means of a 
micro-BCA protein assay kit using bovine serum 
albumin (in the presence of appropriate concentra- 
tions of SDS) as a standard. 
2.5. Western-blot analysis 
Cell fractions containing equal amounts of protein 
(10-20 ~g) were denatured by heating for 30 min at 
60°C in the presence of Laemmli buffer [27] contain- 
ing 10 mM dithiothreitol and were then fractionated 
by sodium dodecyl sulfate-polyacrylamide gel (10%) 
electrophoresis and electroblotted according to stan- 
dard methods [28]. Blots were incubated with rabbit 
serum containing polyclonal antibodies directed 
against he carboxyl-terminal 13-amino-acid peptide 
of GLUT-1 [22] at 1:3000 dilution and polyclonal 
antibodies directed against rat kidney Na,K-ATPase 
e¢l subunit at 1:5000 dilution, following which the 
blots were developed by Enhanced Chemilumines- 
cence. The intensity of the bands was determined by 
densitometry employing a laser scanner (Molecular 
Dynamics Model 300A computing densitometer 
(Sunnyvale, CA)). Integrated band density was shown 
to be linear with the quantity of antigen taken. 
2.6. Statistical methods 
All values are expressed as means + SE. Student's 
unpaired two-tailed t test was used, and a P value of 
< 0.05 was taken to be significant [26]. 
3. Results and discussion 
Previous studies from this laboratory have shown 
that exposure of Clone 9 cells to a maximally stimu- 
latory concentration of T 3 results in an enhancement 
of cytochalasin B-inhibitable glucose uptake that be- 
comes detectable at4-6 h and reaches approximately 
three times the basal rate at 24 h [14,20]. 10 -7 M 
was shown to be a maximally effective concentration 
of T 3, with effects on both active Na,K transport and 
glucose uptake being half-maximal at approximately 
3 × 10 -9  M hormone [20]. Since, in contrast, the 
effect of insulin on Clone 9 cells had not been 
previously described, initial studies were undertaken 
to define both the time-course and maximally effec- 
tive concentration of the hormone on cytochalasin 
B-inhibitable [3H]3-OMG uptake. 
In time-course studies employing 100 nM insulin a 
stimulation of cytochalasin B-inhibitable [3H]3-OMG 
uptake was evident as early as 10 min, with uptake 
rate reaching approximately double the control rate 
by 40 min and thereafter increasing more slowly. 
Stimulation of cytochalasin B-inhibitable [3H]3-OMG 
uptake was half-maximal at 5 nM insulin. Because 
the 'early' effects on glucose transport were the focus 
of the present study, the effect of insulin in all 
subsequent experiments was examined after 40 min 
of exposure. 
We next examined the effects of maximally effec- 
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tive concentrations of T 3 and of insulin both singly 
and in combination. Clone 9 cells grown in medium 
containing hypothyroid calf serum were exposed to 
either 10 -7  M T 3 or  diluent for 24 h, after which 
they were treated with either 10 -7  M insulin or 
diluent for an additional 40 min prior to determina- 
tion of carrier-mediated [3H]3-OMG uptake rate. At 
maximally effective concentrations, insulin and T 3 
stimulated cytochalasin B-sensitive [3H]3-OMG up- 
take 2.3- and 2.7-fold, respectively (Table 1). Of 
particular note was the finding that [3H]3-OMG 
transport was stimulated approximately 5.3-fold in 
the presence of both hormones, a value significantly 
greater than the sum of the stimulatory effects of the 
two hormones acting singly. 
To analyze and compare the effects of the two 
hormones acting singly and in combination, the ratio 
of the observed increment in rate of transport in the 
simultaneous presence of maximally effective con- 
centrations of both insulin and T 3 to the sum of the 
increments induced by the two hormones eparately 
was calculated for each of the nine experiments 
summarized in Table 1. The average of these ratios 
was 1.43 +__ 0.10 (mean + SE; P vs. unity < 0.001), 
showing that the stimulation obtained in the presence 
of the two hormones was substantially more than 
additive. The ratio of the observed stimulation i  the 
presence of both hormones to the calculated product  
of the fold-increase induced by the two hormones 
acting singly was in fact found to be close to unity 
(0.91 ___ 0.08; P vs. un:ity > 0.3), indicating that the 
enhancement of glucose transport obtained in the 
presence of the two hormones was indeed nearly 
multiplicative, i.e., synergistic. 
The finding that the effects of T 3 and insulin on 
glucose transport were synergistic strongly suggested 
that the stimulatory effects of these two hormones are 
mediated by different mechanisms. To determine 
whether the stimulatory effect in either instance might 
be accounted for by an increased abundance of glu- 
cose transporter molecules in the plasma membrane, 
experiments were carried out to examine the effects 
of T 3 and insulin both singly and in combination on 
plasma membrane GLUT-1 abundance. For these ex- 
periments use was made of our recently reported 
method employing mild cell surface biotinylation 
followed by binding of the biotinylated plasma mem- 
branes to immobilized streptavidin and subsequent 
release of plasma membrane proteins by detergent 
treatment [29]. In repeated experiments he yield of 
protein in the plasma membrane fraction averaged 
4.2 + 0.2% of that present in the homogenate. West- 
ern-blot analysis was carried out on duplicate sam- 
pies of post-nuclear supernatant fractions, 'vesicle' 
fractions, and plasma membrane fractions from cells 
exposed to T 3, to insulin, to both hormones, or to 
diluent alone, and the resulting blots were reacted 
simultaneously with antisera to GLUT-1 and to rat 
Na,K-ATPase c~ 1 subunit (see Fig. 1 and Table 2). 
Analysis of the plasma membrane fractions showed 
that the enrichment in oL 1 subunit content (evident in 
lanes 9-12 containing the plasma membranes - - see 
Fig. 1) averaged 5.3 _+ 0.8-fold over the respective 
concentrations in the homogenate and was not signif- 
icantly affected in any of the cell fractions by treat- 
ment of the cells with T 3 or  with insulin either singly 
or in combination. As is also evident in Fig. 1, the 
~ 38 kDa cross-reacting protein band present in the 
Table 1 
Effects of maximally stimulatory concentrations f T3 and insulin on cytochalasin B-inhibitable [3H]3-OMG uptake rate 
Cytochalasin B-inhibitable [-~'H]3-OMG uptake rate 
(ratio to rate in absence ofeither hormone) 
Ratio of increment i  presence ofT 3 and insulin together 
to sum of increments induced by T 3 and insulin separately 
Control Insulin T 3 T 3 + Insulin 
1.00 ± 0.05 2.29 + 0.32 2.72 ___ 0.22 5.28 ___ 0.65 1.43 + 0.10 
P vs. unity < 0.001 
Clone 9 cells grown in hypothyroid calf serum were exposed toeither 10 -7  M T 3 or  diluent for 24 h, after which they were treated with 
either 10 -7  M insulin or diluent for an additional 40 min. [3H]3-OMG uptake rate was then determined in triplicate sets of plates in the 
absence or presence of50 I~M cytochalasin B as described in Section 3. The effects of the two hormones, both singly and in combination, 
on cytochalasin B-sensitive [3H]3-OMG uptake rate were determined in 9 independent experiments and are summarized above. The 
effects of the two hormones acting in consort are substantially more than additive and indeed nearly multiplicative (see text). 
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Fig. 1. Relative GLUT-I content of post-nuclear supernatant 
fractions, 'vesicle' fractions, and plasma membrane fractions 
from control cells and from cells treated with T 3 and insulin 
either singly or in combination. Cells exposed to T 3 or insulin 
either singly or in combination, or with diluent alone ('control'), 
were treated with NHS-LC biotin (0.1 mg/ml) at 4°C for 30 min. 
Following homogenization the resulting mixtures were incubated 
with streptavidin beads and samples prepared and subjected to 
Western-blot analysis as previously described [29]. In each exper- 
iment equal amounts of protein (20 ~g) were loaded in all lanes, 
and following electrophoresis the blots were treated with antisera 
to both GLUT-l and a I Na,K-ATPase subunit and developed by 
means of an Enhanced Chemiluminescence kit.Lanes 1-4, post- 
nuclear supernatant fractions: control, insulin, T3, T 3 + insulin, 
respectively; lanes 5-8, vesicle fractions: control, insulin, T 3, 
T 3 +insulin, respectively; lanes 9-12, plasma membrane frac- 
tions: control, insulin, T 3, T 3 + insulin, respectively. Positions of 
GLUT-1 and of Na,K-ATPase e~l subunit are indicated on the 
right; positions of molecular mass standards are indicated on the 
left. Note that the ~ 38 kDa band present in the 'vesicle' fraction 
(lanes 5-8) is completely absent in the plasma membrane frac- 
tion (lanes 9-12). 
post-nuclear fractions (lanes 1-4) and in the vesicle 
fractions (lanes 5-8)  is completely absent in the 
plasma membrane fractions (lanes 9-12).  This latter 
finding and the enrichment in Na,K-ATPase ~x 1 sub- 
unit are consistent with significant enrichment of the 
plasma membrane fractions. 
GLUT-1 content of the post-nuclear homogenates 
was found to be modestly but consistently increased 
in cells treated with T 3 both in the absence and 
presence of insulin (increases of 1.41- and 1.34-fold, 
respectively, relative to control) but was not affected 
by insulin alone (Table 2). The magnitude of the 
increase induced by T 3 was  virtually identical to that 
reported in an earlier study employing a colorimetric 
method for quantitation of GLUT-1 content in West- 
ern blots of whole-cell homogenates [14]. Exposure 
of cells to insulin or T 3 alone increased plasma 
membrane GLUT- I  content 1.27- and 1.46-fold re- 
spectively, with the former increase failing to reach 
statistical significance. Exposure to T 3 in combina- 
tion with insulin resulted in a 1.52-fold increase in 
plasma membrane GLUT-1 content, a significant ele- 
vation over the control value but an effect that was 
not significantly greater than that of either hormone 
alone. 
The salient feature of the preceding observations i
that, whereas treatment with insulin and with T 3 both 
stimulate glucose transport and result in a modest 
increase in plasma membrane GLUT-1 content, the 
increase in transporter content is small compared to 
the effects of these hormones on glucose uptake. The 
effects of the two hormones on plasma membrane 
GLUT-1 content are moreover not additive, whereas 
their effects on transport are more than additive and 
are indeed nearly multiplicative. The latter observa- 
tions suggest (1) that the actions of both T 3 and 
insulin on glucose transport in Clone 9 cells include 
an activation of glucose transporter molecules pre-ex- 
isting in the plasma membrane, and (2) that the 
mechanisms underlying this activation are different 
for the two hormones. It should be noted that the 
validity of quantitative comparisons between frac- 
tional increments in transport rate and in plasma 
membrane GLUT-1 content is critically dependent 
Table 2 
Effects of T 3 and insulin on GLUT-1 content of post-nuclear homogenates and plasma membrane fractions 
Post-nuclear homogenate P vs. control Plasma membranes P vs. control 
Control 1.00 + 0.10 - - -  1.00 + 0.09 
Insulin 0.93 + 0.09 > 0.6 1.27 ± 0.10 < 0.08 
T 3 1.41 ± 0.15 < 0.05 1.46 ___ 0.15 < 0.03 
T 3 + Insu l in  1.34 ± 0.14 < 0.08 1.52 ___ 0.15 < 0.02 
Clone 9 cells grown in hypothyroid calf serum were exposed to either 10 -7 M T 3 or  diluent for 24 h, after which they were treated with 
either 10 -7  M insulin or diluent for an additional 40 min. The cells were then fractionated and the GLUT°I content of post-nuclear nd 
plasma membrane fractions determined. Results show means + SE for GLUT-1 content obtained in duplicate analyses in 6 independent 
experiments and expressed as ratios to the corresponding control values. 
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upon the purity of the plasma membrane fraction 
because contamination with other cell components 
can potentially result in an erroneous estimation of 
the fold-increase in plasma membrane GLUT-1 sites. 
For this reason the methods employed in the present 
study to obtain plasma membrane fractions were 
those previously developed by us for use in Clone 9 
cells and described in Ref. [29]. In that study both 
standard cell fractionation procedures and a novel 
method of 'mild' surface biotinylation were em- 
ployed to measure plasma membrane GLUT-1 abun- 
dance, with the latter values being normalized to 
protein content or to the abundance of Na,K-ATPase 
txl subunit. In the series of experiments employing 
standard cell fractionation procedures, exposure of 
Clone 9 cells to azide for' 24 h resulted in a 2.2 _ 0.3- 
fold increase in total cell GLUT-1 content hat was 
associated with a 6.3 _ k5-fold rise in plasma mem- 
brane GLUT-1 content. Employing the surface bi- 
otinylation method, a separate series of experiments 
showed a 1.6 + 0.1-fold rise in cell GLUT-1 content 
after 24 h of exposure 1:o azide that was associated 
with a 2.7 +0.3-fold rise in plasma membrane 
GLUT-1 content. These results matched what was 
observed employing immunofluorescence techniques, 
and, importantly, neither method registered any 
change in plasma membrane GLUT-1 content after 
1-2 h of exposure to azide, when no significant 
change in total cell GLUT-1 content was observed. In 
contrast, a significant increase in plasma membrane 
GLUT-1 content was registered by both methods in 
cells exposed to azide for 24 h when total cell 
GLUT-1 content was increased. 
The observations reported here support earlier con- 
clusions that transporter activation plays an important 
role in the stimulation of glucose transport by insulin 
[8,10-12], and additionally show that transporter acti- 
vation likewise plays a significant role in the stimula- 
tory effect of T 3 on glucose transport. While mecha- 
nisms underlying glucose transporter activation re- 
main to be defined, further examples of a stimulation 
of glucose transport mediated at least in part by 
activation of glucose transporter sites pre-existing in 
the plasma membrane now include the stimulation of 
glucose transport by hypoxia in rat myocardium [30] 
and L6 myotubes [31], the early phase of stimulation 
of glucose transport in Clone 9 cells by azide [29], 
and the enhancement of glucose transport resulting 
from exposure of rat adipocytes and 3T3-L1 
adipocytes to cycloheximide [32,33]. 
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